Steffen Eidal - Arctic Bioscience VP Marketing
ABS Stock | NOK 2.06 0.04 1.98% |
Insider
Steffen Eidal is VP Marketing of Arctic Bioscience AS
Phone | 47 95 29 33 84 |
Web | https://www.arctic-bioscience.com |
Arctic Bioscience Management Efficiency
The company has return on total asset (ROA) of (0.1149) % which means that it has lost $0.1149 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2215) %, meaning that it generated substantial loss on money invested by shareholders. Arctic Bioscience's management efficiency ratios could be used to measure how well Arctic Bioscience manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Pal Strom | Scatec Solar OL | 47 | |
Michael Lilja | Napatech AS | N/A | |
Torstein Berntsen | Scatec Solar OL | 53 | |
Carsten Christensen | Kitron ASA | 57 | |
Borge Sorvoll | Arcticzymes Technologies ASA | 48 | |
Jethro Holter | Arcticzymes Technologies ASA | 51 | |
Alexander Bjorna | Arcticzymes Technologies ASA | N/A | |
Raymond Smets | Napatech AS | 60 | |
Tolv Hillestad | Photocure | N/A | |
Jacob Gregersen | Cadeler As | N/A | |
Terje Pilskog | Scatec Solar OL | 52 | |
Iver Olerud | Kongsberg Gruppen ASA | 47 | |
Stian Haugen | Kitron ASA | 47 | |
Kristin Barkost | Kongsberg Gruppen ASA | 69 | |
Stein Eriksen | XXL ASA | N/A | |
Zygimantas Dirse | Kitron ASA | 43 | |
Marit Lorentzen | Arcticzymes Technologies ASA | 55 | |
Pal Wibe | XXL ASA | 55 | |
Mario Robayo | Cadeler As | N/A | |
Darren Ellis | Arcticzymes Technologies ASA | N/A | |
Per Stange | Solstad Offsho | N/A |
Management Performance
Return On Equity | -0.22 | |||
Return On Asset | -0.11 |
Arctic Bioscience Leadership Team
Elected by the shareholders, the Arctic Bioscience's board of directors comprises two types of representatives: Arctic Bioscience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Arctic. The board's role is to monitor Arctic Bioscience's management team and ensure that shareholders' interests are well served. Arctic Bioscience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Arctic Bioscience's outside directors are responsible for providing unbiased perspectives on the board's policies.
Steffen Eidal, VP Marketing | ||
Runhild Gammelster, Global Director | ||
Christer Valderhaug, Chief Officer | ||
Yuming Feng, Exec Devel | ||
Hogne Hallaraker, Founder Officer | ||
Jone Slinning, Chief Officer | ||
MBA MSc, CoFounder Chairman | ||
Daniele Mancinelli, Chief Officer | ||
Alvin Berger, Chief Officer | ||
Per Sbo, Chief Officer |
Arctic Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Arctic Bioscience a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.22 | |||
Return On Asset | -0.11 | |||
Profit Margin | (1.98) % | |||
Operating Margin | (1.86) % | |||
Current Valuation | 145.21 M | |||
Shares Outstanding | 24.38 M | |||
Shares Owned By Insiders | 55.06 % | |||
Shares Owned By Institutions | 9.01 % | |||
Price To Book | 1.05 X | |||
Price To Sales | 14.73 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Arctic Stock
Arctic Bioscience financial ratios help investors to determine whether Arctic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Arctic with respect to the benefits of owning Arctic Bioscience security.